Healthcare is an ever-changing industry with new technology and groundbreaking treatments constantly being developed. In order for companies to research conditions and create innovative treatments, they need some back-up from professionals.
One such professional who is a pioneer in the industry is Dr. Scott Rocklage. With over three decades of experience in healthcare management, Dr. Rocklage is well-established in the competitive industry.
As a managing partner at 5AM Ventures, Dr. Rocklage is responsible for developing strategic leadership plans and responsibilities. 5AM Ventures is an investment company that supports life science companies who are researching new and innovative treatments for a wide range of medical conditions. Dr. Rocklage joined 5AM Ventures in 2003 as a partner and quickly became a managing partner in 2004. Read more: Scott Racklage | Bloomberg
Dr. Rocklage’s work with 5AM Ventures is certainly not his first endeavor in the healthcare industry. After graduating from MIT with a Master’s degree in chemistry, he conducted research at the Richard R. Schrock laboratory. He would then go on to hold various positions in numerous pharmaceutical companies.
He was the Chairman and CEO of Cubist Pharmaceuticals and the Board Chairman of Relypsa and Novira. He was the Executive Chairman of Ilypsa, Miikana and Semprus as well. In addition to his position at 5AM Ventures, Dr. Rocklage is also the Board Chairman of Rennovia, Kinestral and Cidara.
Dr. Rocklage attributes his success in the healthcare industry to staying organized and not being afraid to take risks. He says that not straying from his strengths has helped him excel in business and recommends that other entrepreneurs in the healthcare industry stay true to what they can do well.
For more information on Dr. Scott Rocklage and 5AM Ventures, please visit www.5amventures.com.